Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on June 4, 2025

Blue Jay Gold Announces Acquisition of Skukum Gold Project in the Yukon from Tincorp Metals

Blue Jay Gold Announces Acquisition of Skukum Gold Project in the Yukon from Tincorp Metals

VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Blue Jay Gold Corp. (“Blue Jay” or the “Company”), a private reporting issuer recently spun out of Riverside Resources Inc., and Tincorp Metals Inc. (“Tincorp”) (TSXV: “TIN”; OTCQX: “TINFF”) …

Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology

Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology

CAMBRIDGE, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Journal of the American Society …

aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)

aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)

Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS) assessment at 12 weeks. Efzofitimod was generally safe and well tolerated at all doses. SAN DIEGO, June 04 …

Asia Broadband Approves Shareholder Stock Dividend

Asia Broadband Approves Shareholder Stock Dividend

LAS VEGAS, June 04, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) announced today that the Company’s management and Board of Directors have approved a new stock dividend. The common share dividend will be distributed on …

Marimaca Copper Announces Proposed US$17.7 Million Non-Brokered Private Placement

Marimaca Copper Announces Proposed US$17.7 Million Non-Brokered Private Placement

Not for distribution to U.S. newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities law. VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Marimaca …

AgEagle Aerial Systems Secures International Sale of eBee VISION Drones to Paraguayan Government

AgEagle Aerial Systems Secures International Sale of eBee VISION Drones to Paraguayan Government

Strategic Latin American Deal Expands AgEagle’s Global UAS Presence WICHITA, Kan., June 04, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, announces the sale of two eBee …

Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector

Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector

Greensboro, NC, June 04, 2025 (GLOBE NEWSWIRE) -- Global Technologies, LTD (OTCPK: GTLL), a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold …

reAlpha Appoints Mike Logozzo as CEO to Accelerate Growth

reAlpha Appoints Mike Logozzo as CEO to Accelerate Growth

DUBLIN, Ohio, June 04, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced a strategic leadership transition to support its next phase of growth. Effective …

NobleAI Introduces Powerful, Practical AI Solutions For Chemistry and Energy

NobleAI Introduces Powerful, Practical AI Solutions For Chemistry and Energy

SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- NobleAI announced today commercial availability of its best-in-class VIP (Visualizations, Insights …

Allulose Market Size with 6.5% CAGR, Reaching USD 463.17 Mn by 2031 | The Insight Partners

Allulose Market Size with 6.5% CAGR, Reaching USD 463.17 Mn by 2031 | The Insight Partners

US …

Aquaculture Market Size to Hit 406.44 Billion by 2031, with a 4.3% CAGR, Rising Preference for Sustainable Protein Sources Drives | The Insight Partners

Aquaculture Market Size to Hit 406.44 Billion by 2031, with a 4.3% CAGR, Rising Preference for Sustainable Protein Sources Drives | The Insight Partners

US …

Pet Supplements Market Size to Significant Growth, Reaching USD 3.51 Billion by 2031, Growing at a CAGR of 5.0%, Rising Focus on Health and Wellness of Pets Drives | The Insight Partners

Pet Supplements Market Size to Significant Growth, Reaching USD 3.51 Billion by 2031, Growing at a CAGR of 5.0%, Rising Focus on Health and Wellness of Pets Drives | The Insight Partners

US …

Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET. The …

Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis

Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis

SION-719 and SION-451 were generally well tolerated and achieved desired pharmacokinetic targets that reinforce their potential as either an add-on to standard of care or in a Sionna dual combination Sionna plans to advance SION-719 to a Phase 2a proof-of- …

Eldorado Gold Announces Election of Directors and Results from the 2025 Annual and Special Meeting of Shareholders

Eldorado Gold Announces Election of Directors and Results from the 2025 Annual and Special Meeting of Shareholders

VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or “the Company”) is pleased to announce that all director nominees, as listed in the Management Proxy Circular dated April 15, 2025, were elected as …

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform

REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …

 Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as …

Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide

Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide

Collaboration is designed to implement a highly scalable clinical pathway for Revita in post GLP-1 weight maintenance, pending FDA approval, potentially benefiting millions of eligible patients Rising interest from patients and payers for an off-ramp from …

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP

WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced an update on …

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service